The latest price target for Tectonic Therapeutic (NASDAQ:TECX) was reported by Piper Sandler on June 26, 2024. The analyst firm set a price target for $76.00 expecting TECX to rise to within 12 months (a possible 361.45% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Tectonic Therapeutic (NASDAQ:TECX) was provided by Piper Sandler, and Tectonic Therapeutic initiated their overweight rating.

There is no last upgrade for Tectonic Therapeutic

There is no last downgrade for Tectonic Therapeutic.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tectonic Therapeutic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tectonic Therapeutic was filed on June 26, 2024 so you should expect the next rating to be made available sometime around June 26, 2025.

While ratings are subjective and will change, the latest Tectonic Therapeutic (TECX) rating was a initiated with a price target of $0.00 to $76.00. The current price Tectonic Therapeutic (TECX) is trading at is $16.47, which is within the analyst’s predicted range.